title: Complex hyperkinetic movement disorders associated with POLG mutations.
authors.forename: Matthis
authors.initials: M
authors.lastname: Synofzik
authors.forename: Rebecca
authors.initials: R
authors.lastname: Schüle
authors.forename: Claudia
authors.initials: C
authors.lastname: Schulte
authors.forename: Rejko
authors.initials: R
authors.lastname: Krüger
authors.forename: Tobias
authors.initials: T
authors.lastname: Lindig
authors.forename: Ludger
authors.initials: L
authors.lastname: Schöls
authors.forename: Friedrich
authors.initials: F
authors.lastname: Asmus
mesh_terms: D000328:Adult; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D000074002:DNA Polymerase gamma; D004259:DNA-Directed DNA Polymerase / Q000235:genetics*; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000235:genetics*; D008279:Magnetic Resonance Imaging / Q000379:methods; D009154:Mutation / Q000235:genetics*; D009465:Neuromuscular Agents / Q000627:therapeutic use; D010375:Pedigree
chemical_list: D009465:Neuromuscular Agents; D000074002:DNA Polymerase gamma; D004259:DNA-Directed DNA Polymerase; C413027:POLG protein, human; D019274:Botulinum Toxins, Type A